These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7326045)

  • 21. Validation of the tolbutamide metabolic ratio for population screening with use of sulfaphenazole to produce model phenotypic poor metabolizers.
    Veronese ME; Miners JO; Randles D; Gregov D; Birkett DJ
    Clin Pharmacol Ther; 1990 Mar; 47(3):403-11. PubMed ID: 2311340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of disulfiram on the half life and metabolic clearance rate of diphenylhydantoin and tolbtamide in man.
    Svendsen TL; Kristensen MB; Hansen JM; Skovsted L
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):439-41. PubMed ID: 971708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of phenylbutazone on serum protein binding and pharmacokinetic behavior of sulfadimethoxine in rabbits, dogs and rats.
    Imamura Y; Nakamura H; Otagiri M
    J Pharmacobiodyn; 1989 Apr; 12(4):208-15. PubMed ID: 2795429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Controlled study of 3 sulfonamides in chronic urinary and bronchial infections].
    Piolino M; de Kalbermatten JP; Dobjanski S; Granato D; Schelling JL
    Schweiz Med Wochenschr; 1968 Nov; 98(44):1756-62. PubMed ID: 4884544
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of disease, drugs, and dilution on the binding of sulfonamides in human plasma.
    Anton AH
    Clin Pharmacol Ther; 1968; 9(5):561-7. PubMed ID: 5676798
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of hepatic dysfunction in endotoxin pretreated rats using tolbutamide as a marker.
    Kaka JS; al-Khamis K; Tanira MO
    Eur J Drug Metab Pharmacokinet; 1990; 15(3):203-9. PubMed ID: 2253650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vivo and in vitro serum protein binding of sulfonamides in rabbits].
    Imamura Y; Loo ER; Mori H; Otagiri M
    Yakugaku Zasshi; 1985 Dec; 105(12):1188-91. PubMed ID: 3831325
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum protein binding of tolbutamide in patients treated with antiepileptic drugs.
    Fernández MC; Erill S; Lucena MI; Pita E; Pérez-Alférez N
    Clin Pharmacokinet; 1985; 10(5):451-5. PubMed ID: 3930124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-regulation of phenytoin and tolbutamide metabolism in humans.
    Tassaneeyakul W; Veronese ME; Birkett DJ; Doecke CJ; McManus ME; Sansom LN; Miners JO
    Br J Clin Pharmacol; 1992 Dec; 34(6):494-8. PubMed ID: 1493081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma protein binding of diazepam and tolbutamide in chronic alcoholics.
    Thiessen JJ; Sellers EM; Denbeigh P; Dolman L
    J Clin Pharmacol; 1976 Jul; 16(7):345-51. PubMed ID: 947967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of sulfadimethoxine on thiopental distribution and elimination in rats.
    Yu HY; Sawada Y; Sugiyama Y; Iga T; Hanano M
    J Pharm Sci; 1981 Mar; 70(3):323-6. PubMed ID: 7264902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological properties of 4-sulfanilamido-3,6-dimethoxypyridazine (CS-61)--a new sulfonamide.
    Seki T; Segawa T; Komatsu T; Nakagome T
    Arzneimittelforschung; 1965 Dec; 15(12):1441-5. PubMed ID: 4960234
    [No Abstract]   [Full Text] [Related]  

  • 33. Properties of 3-(1-phenyl-propyl)-4-oxycoumarin (marcoumar) in the plasma when tested in normal cases and under the influence of drugs.
    Seiler K; Duckert F
    Thromb Diath Haemorrh; 1968 Jul; 19(3):89-96. PubMed ID: 5708146
    [No Abstract]   [Full Text] [Related]  

  • 34. Tenidap sodium does not alter the clearance or plasma protein binding of tolbutamide in healthy male volunteers.
    Wilner KD; Gardner MJ
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):39S-42S. PubMed ID: 7547093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigations on plasma levels of sulfamethoxazole in man after single and chronic oral administration alone and in combination with trimethoprim.
    Nolte H; Büttner H
    Chemotherapy; 1974; 20(6):321-30. PubMed ID: 4442290
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacokinetics and metabolic elimination of tolbutamide in female rats: Comparison with male rats.
    Fukuno S; Nagai K; Horii A; Yamamoto K; Konishi H
    Biopharm Drug Dispos; 2018 Jul; 39(7):321-327. PubMed ID: 29978919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influence of allopurinol on the half-life of tolbutamide and rifamycin-SV in blood of healthy volunteers].
    Gentile S; Porcellini M; Foglia F; Loguercio C; Coltorti M
    Boll Soc Ital Biol Sper; 1979 Feb; 55(4):345-8. PubMed ID: 552849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative determination of the bacteriostatically active fraction of sulfonamides and the sum of their inactive metabolites in the body fluids.
    Rieder J
    Chemotherapy; 1972; 17(1):1-21. PubMed ID: 5009465
    [No Abstract]   [Full Text] [Related]  

  • 39. Tolbutamide binding to plasma proteins of young and old human subjects.
    Miller AK; Adir J; Vestal RE
    J Pharm Sci; 1978 Aug; 67(8):1192-3. PubMed ID: 671270
    [No Abstract]   [Full Text] [Related]  

  • 40. [Drug interaction during therapy with tolbutamide. The influence of some commonly used drugs on plasma level and half life in diabetic out-patients (author's transl)].
    Kolenda KD; Grille W; Johnsen K
    Med Klin; 1979 Dec; 74(50):1914-22. PubMed ID: 542176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.